Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 227

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 227
---
), and in accordance with the conditions specified in Section 275,
of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of,
any other applicable provision of the SFA.

Where
our Class A Ordinary Shares are subscribed or purchased under Section 275 of the
SFA by a relevant person which is: (a) a corporation (which is not an accredited
investor as defined in Section 4A of the SFA) the sole business of which is to hold
investments and the entire share capital of which is owned by one or more individuals, each
of whom is an accredited investor; or (b) a trust (where the trustee is not an accredited
investor) whose sole purpose is to hold investments and each beneficiary of the trust is
an individual who is an accredited investor; securities (as defined in Section 239(1) of
the SFA) of that corporation or the beneficiaries’ rights and interest in that trust
shall not be transferred within six months after that corporation or that trust
has acquired the Class A Ordinary Shares under Section 275 of the SFA, except: (1) to
an institutional investor (for corporations under Section 274 of the SFA) or to a relevant
person defined in Section 275(2) of the SFA, or to any person pursuant to an offer
that is made on terms that such shares, debentures and units of shares and debentures of
that corporation or such rights and interest in that trust are acquired at a consideration
of not less than S$200,000 (or its equivalent in a foreign currency) for each transaction,
whether such amount is to be paid for in cash or by exchange of securities or other assets,
and further for corporations, in accordance with the conditions, specified in Section 275
of the SFA; (2) where no consideration is or will be given for the transfer; or (3) where
the transfer is by operation of law.

Notice to Prospective Investors in Switzerland

The
Class A Ordinary Shares will not be publicly offered in Switzerland and will not be listed
on the SIX Swiss Exchange, or SIX, or on any other stock exchange or regulated trading facility
in Switzerland. This prospectus has been prepared without regard to the disclosure standards
for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or
the disclosure standards for listing prospectuses under art.